fda semaglutide shortage resolved february 2025 announcement As of 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A FDA declares Wegovy® and Ozempic®

Acetylation is an important amine-containing substances transformation reaction, and acetyl-CoA is a direct donor of acetyl groups

The company also sent text messages containing a link to cancel their subscription to the compounded semaglutide program to all users

In last months newsletter we highlighted a February 6 statement by Commissioner Makary indicating that the agency would take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies

La ausencia de advertencias especficas no significa que un medicamento sea seguro para todos los usuarios

Your appetite control should feel noticeably different within the first two weeks of a dose increase